Korea United Pharm Inc. (033270.KS) KSC

Currency In KRW

AD

Valuation

Market Cap311.49B
Enterprise Value285.22B
P/E Ratio3.63
PEG Ratio0.03
Price/Sales Ratio0.86
Price/Book Ratio0.62
Enterprise/Revenue0.77
Enterprise/EBITDA3.71

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.26
Operating Margin0.16
AD

Management Effectiveness

Return On Assets0.14
Return On Equity0.17

Income Statement

Revenue288.76B
Revenue/Share18,734.22
Gross Profit175.41B
EBITDA60.47B
Net Income38.31B
Diluted EPS2,614.37

Balance Sheet

Total Cash171.65B
Total Cash/Share10,788.23
Total Debt13.32B
Total Debt/Equity0.03
Current Ratio3.36
Book Value Per Share28,895.42

Price History

52-Week Change-12.29
52-Week High21,800
52-Week Low16,100
Moving Average 50 Days17,816.2
Moving Average 200 Days19,167.4

Statistics

Average Volume32,507
Shares Outstanding14.44M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate610
Trailing Annual Dividend Yield3.42
Payout Ratio0.09
Last Split Factor51:50
Last Split DateJanuary 20, 2014
AD